Covid-19

COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
Biden Gets COVID-19, Takes A Fiesty Dig At Tesla CEO: 'I'm Sick …Of Elon Musk And His Rich Buddies Trying To Buy This Election'
DraftKings Offers $10K Prediction Pool For Trump, Biden Presidential Debate: 11 Questions About Immigration, Inflation, Putin And More
Biden Gets COVID-19, Takes A Fiesty Dig At Tesla CEO: 'I'm Sick …Of Elon Musk And His Rich Buddies Trying To Buy This Election'
DraftKings Offers $10K Prediction Pool For Trump, Biden Presidential Debate: 11 Questions About Immigration, Inflation, Putin And More
Marjorie Taylor Greene Promises To 'Lock Up' Anthony Fauci For Handling Of Pandemic: 'Should Be Tried For Crimes Against Humanity'
Mark Cuban Uses Hypothetical Space Virus Spread By Star Trek Aliens On Mars To Make A Point About Vaccines To Elon Musk

Covid-19 Recent News

Novavax Stock Soars On FDA COVID-19 Update: Fundamental Rally Or Potential Short Squeeze?
Novavax (NASDAQ: NVAX) stock surges on positive COVID-19 vaccine news, with FDA setting a PDUFA review date for April 2025. High trading volume and strong technical indicators make it a compelling investment opportunity.
Viva Las Vegas: Tourists Enjoy Sin City, But Gambling? Depends Where
Las Vegas' record occupancy was offset by lower-than-expected table hold — the money made at a table game during an eight-hour shift.
Fauci Addresses COVID-19 Origins Before House Oversight Committee, Says Family Faced Harassment
Dr. Anthony Fauci testified before the House committee, denying claims of suppressing the lab leak theory of COVID-19's origin. Fauci maintained his stance on animal-to-human transmission and addressed accusations regarding the use of private emails for government business.
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb
Experts predict a small rise in COVID-19 cases as a newly dominant strain spreads. The new strain, KP.2, represents 28% of Covid infections in the U.S. and experts believe its mutations have made the variant more immune evasive. 
Fed Chair Jerome Powell Urges Law Graduates To 'Think Beyond Their Personal Success': 'Little Initiative Can Make All The Difference'
In a recent address at Georgetown University Law Center, Federal Reserve Chair Jerome Powell encouraged graduates to consider public service as a career path. Powell, who is currently isolating after testing positive for COVID-19, shared personal anecdotes about his career in public service.
Fed Chair Jerome Powell Tests Positive For COVID-19, Working From Home
Federal Reserve Chair Jerome Powell, 71, tested positive for COVID-19 and is working from home. Minimal market impact and unclear which variant he contracted.
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Moderna wins a crucial legal battle at the European Patent Office against Pfizer and BioNTech over Covid-19 vaccine patents.
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity, Data Shows
AstraZeneca's Phase 3 SUPERNOVA trial shows sipavibart significantly reduces symptomatic COVID-19 in immunocompromised patients. The trial met primary endpoints, showing effectiveness against various SARS-CoV-2 variants.
Marjorie Taylor Greene Says Slovak PM 'Great' And 'Courageous' Over COVID-19 Vaccine, WHO Stance: 'No Wonder They Shot Him'
AstraZeneca Pulls Plug On Vaxzevria COVID-19 Vaccine Amid Surplus of Updated Vaccines
It is worth noting that AstraZeneca has previously conceded in court documents that Vaxzevria can induce side effects such as blood clots and low blood platelet counts.
Elon Musk Finds 'Smoking Gun' Constitutional Violation As Jim Jordan Challenges Mark Zuckerberg's Facebook To Tell Truth Behind White House Censorship Of Lab Leak Theory
Elon Musk reacts to Rep. Jim Jordan's criticism of the Biden administration's alleged efforts to suppress the COVID-19 lab leak theory, highlighting a potential violation of the First Amendment.
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings
Pfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has declined 34.61% YoY and -10.94% YTD due to COVID-19 revenue decrease. Technical analysis shows bearish trend with potential for further downside.
Jim Cramer Urges Investors To Look Back At Pandemic Era For Market Insights: 'Sometimes The Past Is So Crazy, So Nuts'
Cramer pointed out that stocks continue to be heavily impacted by COVID-19, although the exact influence can be challenging to identify.
Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge
Delaware Judge favors Arbutus and Genevant Sciences in their patent dispute with Moderna over COVID-19 vaccine technology.
Arbutus Stock Soars 20% As It Heads To Trial With Moderna In Covid Vaccine Patent Claim
Arbutus Biopharma soared more than 20% on Wednesday, April 3, after the company received permission to pursue a claim against Moderna in court.
Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares
People Are Getting Married At The Same Pace Like They Did Before COVID-19 Was A Thing, Says CDC
No More 5-Day Isolation Period: CDC Says Those With COVID Can Return To Work, School Under These Conditions
New CDC guidelines allow COVID-19 infected individuals to return to work/school if fever-free for 24 hrs and symptoms improving, easing restrictions.
CDC Urges Second COVID-19 Vaccine Dose For Elderly Americans Amid Rising Hospitalizations
The Centers for Disease Control and Prevention has recommended a second annual COVID-19 vaccine for individuals aged 65 and above. This decision comes in the wake of a significant increase in COVID-19 hospitalizations among older Americans.
Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus
Moderna reports Q4 earnings on Feb. 22. Analysts expect $2.53B in revenue. Stock has faced challenges but potential for recovery with COVID-19 vaccine and FDA approval in 2024.
Bond Investors Brace For Potential Fed Pivot Towards Multiple Rate Cuts
Bond investors are gearing up for a possible change in the Federal Reserve's interest rate policy. The central bank is expected to scrap its interest rate hike stance at its next policy meeting, pointing to potential rate cuts this year—the first since the COVID-19 pandemic began in 2020.
Court Rules Against Trudeau In Canadian Truck Dispute, Bitcoin Expert Calls It A 'National Travesty'
A Canadian federal court determined this week that Prime Minister Justin Trudeau violated the nation's Charter of Rights and Freedoms.
Chinese Lab Secretly Mapped COVID-19 Two Weeks Prior To Official Disclosure: US Records
Having the virus information two weeks earlier "would have helped in the early stages of the outbreak," particularly with putting a more effective testing regimen in place, said Richard Ebright, a microbiologist at Rutgers University.